Healthcare -
Biotechnology - NASDAQ - CH
$ 5.16
-3.55 %
$ 190 M
Market Cap
-2.47
P/E
MOLN - REVENUE
Revenue MOLN - Molecular Partners AG
7.04 M
LAST VALUE
-13.15%
2 YEAR CAGR
-7.43%
5 YEAR CAGR
-14.16%
10 YEAR CAGR